title: Co-receptor choice by V alpha14i NKT cells is driven by Th-POK expression rather than avoidance of CD8-mediated negative selection.
abstract: Mouse natural killer T (NKT) cells with an invariant V alpha14-J alpha18 rearrangement (V alpha14 invariant [V alpha14i] NKT cells) are either CD4(+)CD8(-) or CD4(-)CD8(-). Because transgenic mice with forced CD8 expression in all T cells exhibited a profound NKT cell deficit, the absence of CD8 has been attributed to negative selection. We now present evidence that CD8 does not serve as a coreceptor for CD1d recognition and that the defect in development in CD8 transgene homozygous mice is the result of a reduction in secondary T cell receptor alpha rearrangements. Thymocytes from mice hemizygous for the CD8 transgene have a less severe rearrangement defect and have functional CD8(+) V alpha14i NKT cells. Furthermore, we demonstrate that the transcription factor Th, Poxviruses and Zinc finger, and Krüppel family (Th-POK) is expressed by V alpha14i NKT cells throughout their differentiation and is necessary both to silence CD8 expression and for the functional maturity of V alpha14i NKT cells. We therefore suggest that Th-POK expression is required for the normal development of V alpha14i NKT cells and that the absence of CD8 expression by these cells is a by-product of such expression, as opposed to the result of negative selection of CD8-expressing V alpha14i NKT cells.
authors.affiliation: La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037, USA.
authors.forename: Isaac
authors.initials: I
authors.lastname: Engel
authors.forename: Kirsten
authors.initials: K
authors.lastname: Hammond
authors.forename: Barbara A
authors.initials: BA
authors.lastname: Sullivan
authors.forename: Xi
authors.initials: X
authors.lastname: He
authors.forename: Ichiro
authors.initials: I
authors.lastname: Taniuchi
authors.forename: Dietmar
authors.initials: D
authors.lastname: Kappes
authors.forename: Mitchell
authors.initials: M
authors.lastname: Kronenberg
mesh_terms: D000818:Animals; D018949:Antigens, CD1 / Q000235:genetics / Q000276:immunology; D055610:Antigens, CD1d / Q000235:genetics / Q000276:immunology; D015704:CD4 Antigens / Q000235:genetics; D016827:CD8 Antigens / Q000235:genetics; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology; D015321:Gene Rearrangement; D006720:Homozygote; D006801:Humans; D007694:Killer Cells, Natural / Q000276:immunology*; D008213:Lymphocyte Activation; D051379:Mice; D018345:Mice, Knockout; D008822:Mice, Transgenic; D011948:Receptors, Antigen, T-Cell / Q000235:genetics / Q000276:immunology
chemical_list: D018949:Antigens, CD1; D055610:Antigens, CD1d; D015704:CD4 Antigens; D016827:CD8 Antigens; D011948:Receptors, Antigen, T-Cell
references.citation: Science. 2001 Nov 30;294(5548):1936-9
references.pmid: 11729321
references.citation: Blood. 1998 Nov 15;92(10):3780-92
references.pmid: 9808572
references.citation: Proc Natl Acad Sci U S A. 1998 Oct 13;95(21):12492-7
references.pmid: 9770513
references.citation: Proc Natl Acad Sci U S A. 1998 Jul 7;95(14):8187-92
references.pmid: 9653162
references.citation: Curr Opin Immunol. 2005 Apr;17(2):122-30
references.pmid: 15766670
references.citation: Hum Gene Ther. 1996 Aug 1;7(12):1405-13
references.pmid: 8844199
references.citation: Eur J Immunol. 2002 Dec;32(12):3453-62
references.pmid: 12442327
references.citation: J Immunol. 2000 Aug 1;165(3):1236-42
references.pmid: 10903721
references.citation: J Immunol. 1998 Apr 15;160(8):3681-8
references.pmid: 9558068
references.citation: Science. 2008 Feb 8;319(5864):822-5
references.pmid: 18258917
references.citation: J Exp Med. 1994 Sep 1;180(3):1097-106
references.pmid: 7520467
references.citation: J Immunol. 2006 Feb 15;176(4):2064-8
references.pmid: 16455960
references.citation: J Exp Med. 1985 Aug 1;162(2):528-45
references.pmid: 3894562
references.citation: Immunity. 2008 Dec 19;29(6):876-87
references.pmid: 19062319
references.citation: Nature. 1996 Dec 12;384(6609):577-81
references.pmid: 8955273
references.citation: Immunity. 2005 Jun;22(6):705-16
references.pmid: 15963785
references.citation: J Immunol. 1997 Mar 1;158(5):2143-9
references.pmid: 9036959
references.citation: Eur J Immunol. 2005 May;35(5):1399-407
references.pmid: 15816002
references.citation: Immunity. 2008 Mar;28(3):346-58
references.pmid: 18342007
references.citation: Nature. 2005 Feb 24;433(7028):826-33
references.pmid: 15729333
references.citation: Science. 1994 Mar 25;263(5154):1774-8
references.pmid: 7907820
references.citation: J Exp Med. 2006 Mar 20;203(3):661-73
references.pmid: 16505140
references.citation: Immunity. 2006 Sep;25(3):487-97
references.pmid: 16949316
references.citation: J Immunol. 2007 Aug 15;179(4):2228-34
references.pmid: 17675483
references.citation: J Exp Med. 2003 Oct 6;198(7):1069-76
references.pmid: 14530376
references.citation: Appl Theor Electrophor. 1990;1(4):181-7
references.pmid: 1982991
references.citation: Nat Rev Immunol. 2008 Oct;8(10):788-801
references.pmid: 18802443
references.citation: Immunity. 2008 Sep 19;29(3):391-403
references.pmid: 18703361
references.citation: J Exp Med. 2008 Jan 21;205(1):245-56
references.pmid: 18195075
references.citation: Proc Natl Acad Sci U S A. 1999 Feb 2;96(3):996-1001
references.pmid: 9927682
references.citation: J Exp Med. 2005 Aug 15;202(4):485-92
references.pmid: 16087715
references.citation: Nat Immunol. 2005 Apr;6(4):373-81
references.pmid: 15750595
references.citation: Nat Immunol. 2008 Sep;9(9):1055-64
references.pmid: 18660811
references.citation: J Exp Med. 2001 Aug 20;194(4):471-80
references.pmid: 11514603
references.citation: J Exp Med. 2003 Apr 7;197(7):907-18
references.pmid: 12682110
references.citation: J Exp Med. 2006 Nov 27;203(12):2639-48
references.pmid: 17088433
references.citation: Immunity. 1997 Apr;6(4):469-77
references.pmid: 9133426
references.citation: J Immunol. 1998 Nov 15;161(10):5124-8
references.pmid: 9820479
references.citation: Science. 2002 Apr 19;296(5567):553-5
references.pmid: 11968185
references.citation: Cell. 1991 May 3;65(3):443-9
references.pmid: 1673361
references.citation: J Immunol. 2002 Aug 1;169(3):1340-8
references.pmid: 12133957
references.citation: J Exp Med. 2002 Nov 4;196(9):1163-73
references.pmid: 12417627
references.citation: Proc Natl Acad Sci U S A. 2005 Apr 5;102(14):5114-9
references.pmid: 15792999
references.citation: Nat Rev Immunol. 2004 Mar;4(3):231-7
references.pmid: 15039760
references.citation: Cell. 1991 Jan 11;64(1):99-107
references.pmid: 1898873
references.citation: Science. 1999 Nov 5;286(5442):1149-53
references.pmid: 10550051
references.citation: J Immunol. 1998 Oct 1;161(7):3271-81
references.pmid: 9759842
references.citation: Science. 1995 May 12;268(5212):863-5
references.pmid: 7538697
references.citation: Nat Med. 2008 Apr;14(4):437-41
references.pmid: 18345012
references.citation: J Exp Med. 1996 Oct 1;184(4):1285-93
references.pmid: 8879200
references.citation: J Immunol. 2001 Oct 15;167(8):4485-93
references.pmid: 11591775
references.citation: Nat Rev Immunol. 2002 Aug;2(8):557-68
references.pmid: 12154375
references.citation: Nat Rev Microbiol. 2007 Jun;5(6):405-17
references.pmid: 17487145
references.citation: J Exp Med. 1995 Dec 1;182(6):2091-6
references.pmid: 7500054
references.citation: J Exp Med. 2006 May 15;203(5):1197-207
references.pmid: 16651387
references.citation: Curr Opin Immunol. 2007 Apr;19(2):186-93
references.pmid: 17303398